Menopause associated with increased prevalence of cardiovascular autonomic neuropathy in women with diabetes: this study

Published Date: 02 Mar 2023

Spain: A recent study showed an increase in subclinical autonomic neuropathy (CAN) in women aged 1...

Read Full News

Latest News

Lilly CEO Sees Weight-loss Drugs Reaching About Half Of Potential Users At Peak

Weight-loss drugs may eventually reach only about 50% of the overweight and obese people who could benefit from them due to complexities of healthcare systems ⁠and financial...

Restrictive Food Disorder Prevalence Overestimated

Avoidant/restrictive food intake disorder was inconsistently identified in patients with GI disorders, likely leading to overestimation of its prevalence.

‘Secret Shopper’ Study Finds Risks in Compounded GLP-1s

Study on compounded GLP-1s uncovers use of additives and questionable sterility practices, revealing legally ‘murky’ area.

M1 Variant Lowers APOL1 Kidney Disease Risk

Although APOL1 variants are linked to kidney disease risk, the presence of the M1 genetic variant appears to reduce that risk.

Weekend Catch-Up Sleep May Harm Glucose Control

A large NHANES analysis suggests that 7 hours of sleep may represent a metabolic sweet spot, whereas too little, too much, or excessive weekend catch-up sleep may worsen insulin resistance.

Microbiome May Predict Fiber-Induced Bloating

Few patients with bloating experience symptoms from fermentable fibers, with predictors including a higher baseline symptom burden and distinct gut microbiome patterns.

Todays Updates

Can Oncotype Predict Recurrence Risk in Older BC Patients?

A recent study assesses whether Oncotype DX can predict local recurrence risk in older, lower-risk patients with breast cancer who omit adjuvant radiation.

Todays Updates

Can Oncotype Predict Recurrence Risk in Older BC Patients?

A recent study assesses whether Oncotype DX can predict local recurrence risk in older, lower-risk patients with breast cancer who omit adjuvant radiation.

Latest News

Weight-loss drugs may eventually reach only about 50% of the overweight and obese people who could benefit from them due to complexities of healthcare systems ⁠and financial...

Avoidant/restrictive food intake disorder was inconsistently identified in patients with GI disorders, likely leading to overestimation of its prevalence.

Study on compounded GLP-1s uncovers use of additives and questionable sterility practices, revealing legally ‘murky’ area.

Although APOL1 variants are linked to kidney disease risk, the presence of the M1 genetic variant appears to reduce that risk.

A large NHANES analysis suggests that 7 hours of sleep may represent a metabolic sweet spot, whereas too little, too much, or excessive weekend catch-up sleep may worsen insulin resistance.

Few patients with bloating experience symptoms from fermentable fibers, with predictors including a higher baseline symptom burden and distinct gut microbiome patterns.

News All Time

Managing Care When Gender-Affirming Therapy Is Limited

As access to gender-affirming care for minors narrows, clinicians are adapting — using nonhormonal options, stronger mental health support, and creative, patient-centered strategies.

Postmenopausal HRT Tied to Glaucoma Risk in Women

The use of postmenopausal hormone replacement therapy is associated with an increased risk for glaucoma in Finnish women aged 50 years or older, according to a recent nested case-control study.

Novo Nordisk Launches Wegovy Subscription Program

The telehealth platform program saves money for some self-pay patients, but experts express concerns about fragmentation of care.

Incretin-Based Drugs Show Superior Glycemic Profiles on CGM

Continuous glucose monitoring in the GRADE trial shows that incretin-based drugs such as sitagliptin and liraglutide produce the most stable glycemic profiles and show the lowest hypoglycemia risk.

Recent Depression Tied to Treatment Intensification in T2D

Patients with T2D who have a history of depression, especially a recent episode, are more likely to undergo earlier treatment intensification and insulin initiation than those who do not.

US FDA Weighs Broader Use Of Testosterone Therapy for Low Sex Drive in Men

The U.S. Food and Drug Administration is considering approving testosterone replacement therapy ⁠to treat low sex drive in men whose bodies do not produce enough of ⁠the...

Tirzepatide Best for Weight Loss in Adults Without T2D

High doses of the dual agonist tirzepatide appear to provide greater weight loss than other GLP-1s among adults with overweight or obesity who don’t have type 2 diabetes.

Knee Osteoarthritis Pain Relief Seen With Neurotrophin-3 Inhibition

A p75 neurotrophin receptor fusion protein reduces pain and improves function in patients with knee osteoarthritis across all tested doses and shows favorable safety outcomes in a phase 2 trial.

How Limited Is Evidence for Preventing Nephrolithiasis?

A systematic review finds limited evidence that selected drugs and hydration may reduce the risk for kidney stone recurrence.

Can Genes Affect GLP-1 Side Effects and Treatment Outcomes?

Two genetic variants may help explain differences in side effects and weight loss in patients taking GLP-1 drugs.

Lower Albumin Levels Linked to Fracture Risk in Older Women

Lower levels of serum albumin and lower values of a nutrition-related index are associated with a higher risk for fracture in older women.

Revolution Medicines' Experimental Cancer Pill Boosts Survival in Late-stage Study

Revolution Medicines' experimental oral drug helped patients with pancreatic cancer live nearly twice as long as those treated ⁠with chemotherapy in a keenly anticipated...

SGLT2 Therapy Linked to Higher Ketoacidosis Risk in T2D

SGLT2 inhibitor therapy is linked to an increased risk for diabetic ketoacidosis in adults with T2D, particularly among those with elevated baseline A1c levels, a recent meta-analysis shows.

Fighting Outbreaks One Conversation at a Time

From Hackney to West Yorkshire, a GP and a public health researcher are tackling vaccine hesitancy by reaching the families mainstream messaging leaves behind.

Ginger Dietary Supplement May Ease GLP-1-Related Nausea

Primary endpoint didn’t reach significance, but secondary endpoints showed nausea reduction with herbal supplement from Dramamine maker.

FDA Requires Lilly to Conduct Post-marketing Studies for Obesity Pill

The ⁠U.S. Food and ⁠Drug Administration said ⁠Eli ‌Lilly is required to conduct post-marketing ‌trials to gauge risks ‌for ‌liver injury, cardiovascular ⁠events, ‌gastric...

Recommended News For You

Small-Town Patients Face Big Hurdles as Rural Hospitals Cut Cancer Care

In Relapsed/Refractory Myeloma, Blenrep-Based Regimen Produces PFS Advantage.

The most precise research tools for the deadliest blood cancer have been developed.

Avoiding Neuropathy From Chemo; Predictive Value of Screening EKGs

Short Shrift in Cancer Funding; Bypassing Familiar for Distant; Testing for BRCA.

GLP-1 RAs May Lower Hysterectomy Risk in Endometrial Cancer

Drug-chemo combo increases cancer treatment efficacy

Recommended Articles For You

Integrative Cancer Care: Nutrition, Social Work, Care Coordination, and Genetic Counseling 

Unraveling the Mysteries of Burkitt Lymphoma: A New Hope for Treatment 

Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage 

Improving TIVAP Use: Review of Standardization and Optimization Practices 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

FDA-approved FGFR inhibitors show promise against rare and aggressive pediatric brain tumor

2.

Canine Cancer Vaccine: A Potential Resurrection? U.S. KK. Snubs Enertu.

3.

VP Nominee Medical Records Breached; Queen Elizabeth's Cancer; Galaxy Gas Whippets

4.

Hospitalized Kate Middleton; Sen. Paul Demands That Fauci Go To Prison; COVID Returns to Class.

5.

Even after a partial ban, asbestos is still used and is a deadly carcinogen, according to the EPA.

1.

Unraveling the Mystery of Non-Caseating Granulomas: A Comprehensive Guide

2.

Unlocking the Secrets of Ringed Sideroblasts: A New Frontier in Hematology

3.

Phosphate Vs. Phosphorus: What Is The Difference?

4.

Ethics of Experimental Oncology: Case Study on Autonomy, Consent & Decision-Making

5.

Fibroma: Understanding the Causes, Symptoms, and Treatment Options

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

2.

Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer

3.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma

4.

Efficient Management of First line ALK-rearranged NSCLC - Part II

5.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot